Clinical Trial Update: Optiflow® to Prevent Post-Extubation Hypoxemia afteR Abdominal Surgery (the OPERA Trial) [Phase 4]

View source ↗

Summary

Phase 4 OPERA trial completed, evaluating Optiflow high-flow nasal oxygen to prevent post-extubation hypoxemia after abdominal surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxemia

Drugs mentioned

• Optiflow (nasal high-flow oxygen therapy device)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Postoperative Hypoxemia | Phase 4 | Status: COMPLETED